The real-world effectiveness of fluvoxamine therapy in mild to moderate COVID-19 patients; A historical cohort study (Fluvoxa Trial).
J Infect Public Health
; 16(12): 2010-2016, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37890224
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Clinical Deterioration
/
COVID-19
Limits:
Humans
Language:
En
Journal:
J Infect Public Health
Journal subject:
DOENCAS TRANSMISSIVEIS
/
SAUDE PUBLICA
Year:
2023
Document type:
Article
Country of publication:
Reino Unido